Need Help?

Hi-C datasets of primary glioblastoma cultures

High-resolution (Sub-5 kbp resolution) Hi-C datasets generated using glioblastoma primary cultures from 3 different adult patients.

Request Access

Access to genomics data

1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify University of Calgary within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify University of Calgary prior to any significant changes to the protocol for the Project. 14. The User Institution will notify University of Calgary as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. University of Calgary may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than University of Calgary. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003493 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002441443 fastq.gz 13.1 GB
EGAF00002441444 fastq.gz 13.1 GB
EGAF00002441445 fastq.gz 13.6 GB
EGAF00002441446 fastq.gz 13.5 GB
EGAF00002441447 fastq.gz 13.5 GB
EGAF00002441448 fastq.gz 13.5 GB
EGAF00002441449 fastq.gz 11.9 GB
EGAF00002441450 fastq.gz 12.1 GB
EGAF00002441451 fastq.gz 12.6 GB
EGAF00002441452 fastq.gz 12.9 GB
EGAF00002441453 fastq.gz 12.9 GB
EGAF00002441454 fastq.gz 13.1 GB
EGAF00002441455 fastq.gz 11.1 GB
EGAF00002441456 fastq.gz 11.5 GB
EGAF00002441457 fastq.gz 11.8 GB
EGAF00002441458 fastq.gz 12.1 GB
EGAF00002441459 fastq.gz 12.0 GB
EGAF00002441460 fastq.gz 12.3 GB
EGAF00002441461 fastq.gz 11.6 GB
EGAF00002441462 fastq.gz 11.8 GB
EGAF00002441463 fastq.gz 12.4 GB
EGAF00002441464 fastq.gz 12.7 GB
EGAF00002441465 fastq.gz 12.0 GB
EGAF00002441466 fastq.gz 12.3 GB
EGAF00002441467 fastq.gz 13.6 GB
EGAF00002441468 fastq.gz 13.9 GB
EGAF00002441469 fastq.gz 13.5 GB
EGAF00002441470 fastq.gz 13.8 GB
EGAF00002441471 fastq.gz 10.3 GB
EGAF00002441472 fastq.gz 10.5 GB
EGAF00002441473 fastq.gz 10.3 GB
EGAF00002441474 fastq.gz 10.5 GB
EGAF00002441475 fastq.gz 888.3 MB
EGAF00002441476 fastq.gz 890.3 MB
EGAF00002441477 fastq.gz 814.3 MB
EGAF00002441478 fastq.gz 814.1 MB
EGAF00002441479 fastq.gz 955.1 MB
EGAF00002441480 fastq.gz 957.4 MB
EGAF00002441481 fastq.gz 1.2 GB
EGAF00002441482 fastq.gz 1.2 GB
EGAF00002441483 fastq.gz 1.1 GB
EGAF00002441484 fastq.gz 1.1 GB
EGAF00002441485 fastq.gz 1.1 GB
EGAF00002441486 fastq.gz 1.2 GB
EGAF00002446719 fastq.gz 13.1 GB
EGAF00002446720 fastq.gz 13.1 GB
EGAF00002446721 fastq.gz 13.6 GB
EGAF00002446722 fastq.gz 13.5 GB
EGAF00002446723 fastq.gz 13.5 GB
EGAF00002446724 fastq.gz 13.5 GB
EGAF00002446725 fastq.gz 11.9 GB
EGAF00002446726 fastq.gz 12.1 GB
EGAF00002446727 fastq.gz 12.6 GB
EGAF00002446728 fastq.gz 12.9 GB
EGAF00002446729 fastq.gz 12.9 GB
EGAF00002446730 fastq.gz 13.1 GB
EGAF00002446731 fastq.gz 11.1 GB
EGAF00002446732 fastq.gz 11.5 GB
EGAF00002446733 fastq.gz 11.8 GB
EGAF00002446734 fastq.gz 12.1 GB
EGAF00002446735 fastq.gz 12.0 GB
EGAF00002446736 fastq.gz 12.3 GB
EGAF00002446737 fastq.gz 11.6 GB
EGAF00002446738 fastq.gz 11.8 GB
EGAF00002446739 fastq.gz 12.4 GB
EGAF00002446740 fastq.gz 12.7 GB
EGAF00002446741 fastq.gz 12.0 GB
EGAF00002446742 fastq.gz 12.3 GB
EGAF00002446743 fastq.gz 13.6 GB
EGAF00002446744 fastq.gz 13.9 GB
EGAF00002446745 fastq.gz 13.5 GB
EGAF00002446746 fastq.gz 13.8 GB
EGAF00002446747 fastq.gz 10.3 GB
EGAF00002446748 fastq.gz 10.5 GB
EGAF00002446749 fastq.gz 10.3 GB
EGAF00002446750 fastq.gz 10.5 GB
EGAF00002446751 fastq.gz 888.3 MB
EGAF00002446752 fastq.gz 890.3 MB
EGAF00002446753 fastq.gz 814.3 MB
EGAF00002446754 fastq.gz 814.1 MB
EGAF00002446755 fastq.gz 955.1 MB
EGAF00002446756 fastq.gz 957.4 MB
EGAF00002446757 fastq.gz 1.2 GB
EGAF00002446758 fastq.gz 1.2 GB
EGAF00002446759 fastq.gz 1.1 GB
EGAF00002446760 fastq.gz 1.1 GB
EGAF00002446761 fastq.gz 1.1 GB
EGAF00002446762 fastq.gz 1.2 GB
88 Files (815.8 GB)